NAF Early Career Investigator Award supports early-career scientists with seed funding for independent research into ataxia’s causes, mechanisms, or treatment to advance understanding and therapies.
Funder: National Ataxia Foundation
Due Dates: November 1, 2026 (LOI questions) | November 18, 2026 (Letter of Intent) | February 12, 2027 (Full application questions) | March 1, 2027 (Full application)
Funding Amounts: Up to $50,000 for one year (September 1, 2027–August 31, 2028), nonrenewable
Summary: Seed funding helps early-career investigators establish independent research programs advancing understanding or treatment of ataxia.
Key Information: Previous NAF Early Career Investigator awardees and Associate Professors are ineligible.
The National Ataxia Foundation (NAF) Early Career Investigator Award supports outstanding early-stage scientists developing independent research careers. Part of NAF’s Annual Research Grant Program, this merit-based award provides short-term seed funding for innovative, high-impact basic, translational, and clinical research. Projects must have a clear and significant focus on the causes, pathogenesis, or treatment of hereditary, sporadic, or acquired ataxias. Research with only indirect, incidental, or tangential relevance to ataxia is not responsive to program priorities.
The program aims to catalyze meaningful scientific insights and therapeutic advances while helping investigators build a foundation for long-term funding. Priorities include fundamental disease mechanisms, development and validation of disease models, emerging therapeutic targets or strategies, and pilot data supporting future external grant applications. A sustained commitment to ataxia research and a clear path toward research independence are important, with mentorship, institutional support, critical resources, and skill-building encouraged.